IGF-1 LR3 Deus Medical

IGF-1 LR3 | 1 mg – Deus Medical

IGF-1 LR3 (Long R3 Insulin-like Growth Factor 1) is a synthetic, long-acting analog of the naturally occurring human IGF-1 peptide.¹ It is modified to have an extended half-life and greater systemic effect compared to standard IGF-1.²

The LR3 modification prevents the peptide from binding strongly to the majority of its plasma binding proteins (IGFBPs).³ This dramatically extends its activity from minutes to 20–30 hours, allowing it to circulate throughout the body for much longer, binding to receptors and stimulating powerful anabolic effects.⁴

Core Performance Benefits

• Sustained Anabolic Action: Used to stimulate cell growth, muscle recovery, and fat burning over a prolonged period.⁵ The long half-life provides sustained anabolic signaling throughout the day.

• Muscle Growth and Recovery: It enhances protein synthesis and inhibits protein degradation, leading to the growth of more muscle tissue and significantly faster recovery times post-workout.⁶

• Fat Loss: Aids in dissolving fat deposits and improving metabolism, contributing to overall body recomposition.⁷

• Hyperplasia Potential: Research suggests IGF-1 may stimulate muscle cell hyperplasia (creating new muscle fibers) rather than just hypertrophy (enlarging existing fibers), potentially offering long-term growth capacity.

Usage and Dosage Protocols

IGF-1 LR3 is typically administered infrequently due to its extended half-life.⁸

Side Effects and Warnings

IGF-1 LR3 is a potent growth factor; its misuse can have serious health effects, mimicking those of excessive growth hormone.

• Hypoglycemia Risk: The most common acute side effect is low blood sugar, as IGF-1 is structurally similar to insulin. Users must consume fast-acting carbohydrates around dosing time.⁹

• Excessive Growth: Abuse can lead to potential organ enlargement (acromegaly), nerve impingement (joint pain/carpal tunnel), and potential harm to the heart.¹⁰

• Cancer Risk: Due to its ability to stimulate cell division, chronic elevation of IGF-1 is linked to a potential increase in the risk of certain cancers.¹¹

Frequently Asked Questions (FAQs)

1. What makes the LR3 variant long-acting?

The LR3 modification reduces the peptide’s affinity for binding proteins (IGFBPs) that usually neutralize IGF-1 rapidly.12 This allows it to remain active for up to 30 hours, enabling once-daily dosing.13

2. Subcutaneous or Intramuscular injection?

Subcutaneous (into the fat layer) is preferred for a systemic anabolic effect across the whole body. Intramuscular injection is more commonly associated with the IGF-1 DES variant for localized growth.

3. Does it require Post Cycle Therapy (PCT)?

No. IGF-1 LR3 is a growth factor peptide. It does not suppress the body’s natural production of testosterone, so standard PCT protocols are not required.

4. Why is organ growth a risk?

As a master anabolic hormone, IGF-1 stimulates cell division in nearly all tissue types. While beneficial for muscle, abuse can cause undesirable growth in organs (like the heart) or bone structure (jaw, hands, feet).